New billing guidance for osteogenesis stimulators

The FDA issued a final order in the Federal Register in April to reclassify non-invasive bone growth stimulators from class III to class II devices. The following Healthcare Common Procedure Coding System (HCPCS) codes now only describe class II devices:

• E0747 (Osteogenesis stimulator, electrical, non-invasive, other than spinal applications)
• E0748 (Osteogenesis stimulator, electrical, non-invasive, spinal applications
• E0760 (Osteogenesis stimulator, low intensity ultrasound, non-invasive)

Claims with these HCPCS codes with dates of service on or after May 18 must be billed without modifier -KF, which is used to report class III devices. Claim lines billed for these dates of service with the modifier will be rejected as incorrectly coded.

CMS plans to update the fee schedule amounts for these codes to reflect the change, and it will include the recalculated fees in the July 2026 Durable Medical Equipment, Prosthetics, Orthotics, and Supplies fee schedule update.